Johnson & Johnson (JNJ) Payables (2009 - 2026)

Johnson & Johnson has disclosed Payables across 18 years of filings, most recently posting $20.9 billion for Q2 2026.

• In Q2 2026, Payables changed 0.36% year-over-year to $20.9 billion; the TTM figure through Jun 2026 stood at $20.9 billion (changed 0.36% YoY), while the FY2025 annual figure was $20.5 billion, up 25.73% from the prior year.
• Payables came in at $20.9 billion for Q2 2026 at Johnson & Johnson, down from $27.9 billion in the prior quarter.
• In the past five years, Payables ranged from a high of $27.9 billion in Q1 2026 to a low of $12.2 billion in Q4 2023.
• Average Payables over 5 years is $18.4 billion, with a median of $16.7 billion recorded in 2024.
• The largest YoY upside for Payables was 104.97% in 2023 against a maximum downside of 42.23% in 2023.
• Over 5 years, Payables stood at $14.6 billion in 2022, then retreated by 10.25% to $13.1 billion in 2023, then grew by 24.54% to $16.3 billion in 2024, then increased by 25.73% to $20.5 billion in 2025, then gained by 2.09% to $20.9 billion in 2026.
• Per Business Quant data, the three most recent Payables figures were $20.9 billion in Q2 2026, $27.9 billion in Q1 2026, and $20.5 billion in Q4 2025.